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Abstract
Gliomas, the most common malignant tumors of the nervous system, frequently harbor mutations that activate the
epidermal growth factor receptor (EGFR) and phosphatidylinositol-3 kinase (PI3K) signaling pathways. To investigate the
genetic basis of this disease, we developed a glioma model in Drosophila. We found that constitutive coactivation of EGFR-
Ras and PI3K pathways in Drosophila glia and glial precursors gives rise to neoplastic, invasive glial cells that create
transplantable tumor-like growths, mimicking human glioma. Our model represents a robust organotypic and cell-type-
specific Drosophila cancer model in which malignant cells are created by mutations in signature genes and pathways
thought to be driving forces in a homologous human cancer. Genetic analyses demonstrated that EGFR and PI3K initiate
malignant neoplastic transformation via a combinatorial genetic network composed primarily of other pathways commonly
mutated or activated in human glioma, including the Tor, Myc, G1 Cyclins-Cdks, and Rb-E2F pathways. This network acts
synergistically to coordinately stimulate cell cycle entry and progression, protein translation, and inappropriate cellular
growth and migration. In particular, we found that the fly orthologs of CyclinE, Cdc25, and Myc are key rate-limiting genes
required for glial neoplasia. Moreover, orthologs of Sin1, Rictor, and Cdk4 are genes required only for abnormal neoplastic
glial proliferation but not for glial development. These and other genes within this network may represent important
therapeutic targets in human glioma.
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Introduction
Malignant gliomas, neoplasms of glial cells and their precursors,
are the most common tumors of the central nervous system (CNS).
These tumors typically proliferate rapidly, diffusely infiltrate the
brain, and resist standard chemotherapies, properties that render
them largely incurable. One key to developing more effective
therapies against these tumors is to understand the genetic and
molecular logic underlying gliomagenesis. The most frequent
genetic lesions in gliomas include mutation or amplification of the
Epidermal Growth Factor Receptor (EGFR) tyrosine kinase.
Glioma-associated EGFR mutant forms show constitutive kinase
activity that chronically stimulates Ras signaling to drive cellular
proliferation and migration [1,2]. Other common genetic lesions
include loss of the lipid phosphatase PTEN, which antagonizes the
phosphatidylinositol-3 kinase (PI3K) signaling pathway, and
activating mutations in PIK3CA, which encodes the p110a
catalytic subunit of PI3K [1,2]. Gliomas often show constitutively
active Akt, a major PI3K effector [1,2]. However, EGFR-Ras or
PI3K mutations alone are not sufficient to transform glial cells,
rather multiple mutations that coactivate EGFR-Ras and PI3K-
Akt pathways are sufficient to induce glioma [2–4].
Understanding the interplay of these mutations and the
neurodevelopmental origins of these tumors could lead to new
insights into the mechanisms of gliomagenesis. The mammalian
brain contains multiple glial cell types that maintain proliferative
capacities, including differentiated astrocytes, glial progenitors,
and multipotent neural stem cells. EGFR-Ras and PTEN-PI3K
signaling regulates many developmental processes in these cell
types, particularly proliferation and self-renewal, which are also
properties of glioma cells [1]. Although recent hypotheses favor
that gliomas arise from multipotent stem cells, data from mouse
models demonstrate that differentiated glia, glial progenitors, and
stem cells can all produce gliomas in response to genetic lesions
found in human gliomas [5,6]. Thus, misregulation of these
genetic pathways may confer unrestricted proliferative capacities
to a range of glial cell types, but how this occurs remains unclear.
While many of the same effectors are utilized by EGFR-Ras and
PI3K in both glial development and cancer, constitutive activation
of these pathways may deploy distinct outputs, not utilized in
development, that allow particular cells to escape normal
physiological cues that restrain proliferation and self-renewal.
The identity of such outputs remains unclear.
With these issues in mind, we developed a Drosophila glioma model
to facilitate genetic analysis of glial pathogenesis. Drosophila offers
many tools for precise manipulation of cell-type-specific gene
expression and dissection of multigene interactions. Most human
genes, including 70% of known disease genes, have functional
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components of major signal transduction pathways, including many
gliomagenic genes. Recently, Drosophila has emerged as a model
system for human neurological diseases because the CNS shows
remarkable evolutionary conservation in cellular composition and
neurodevelopmental mechanisms [8]. Similarly, Drosophila have
multiple glial cell types that require the EGFR pathway for their
normal development, and these cells appear homologous to
mammalian glia in terms of function, development, and gene
expression [9]. These similarities between flies and humans make
Drosophila an attractive system for modeling gliomas.
Results
Coactivation of EGFR-Ras and PI3K in Drosophila Glia
Causes Neoplasia
Since concurrent activation of EGFR-Ras and PI3K signaling
in glial precursors induces glioma in the mouse [4], we sought to
create mutant phenotypes by hyperactivation of these pathways in
fly glia and glial precursors. Drosophila has a single functional
ortholog each for EGFR(dEGFR), Raf (dRaf), PIK3CA(dp110),
PTEN(dPTEN), and Akt(dAkt), and two functional orthologs for
Ras(dRas85D, dRas64B) (www.flybase.org). A diagram of the
specific mutant forms of dEGFR used in our assays can be found
in Figure S1. We performed glial overexpression assays with the
Gal4-UAS system [10], using the repo-Gal4 driver, which gives
sustained UAS-transgene expression in almost all glia, from
embryogenesis through adulthood. For glial-specific RNAi, we
employed UAS-dsRNA constructs [11], which we verified with
phenotypic tests and/or antibody staining (see Materials and
Methods). Glial morphology was visualized with membrane-
localized GFP (CD8GFP) [12]. Cell number was determined with
staining for Repo, a homeobox transcription factor expressed by
repo-Gal4 positive glia [13].
Glial-specific coactivation of EGFR-Ras and PI3K stimulated
glial neoplasia, giving rise to CNS enlargement and malformation,
neurologic defects, and late larval lethality. repo-Gal4-driven co-
overexpression of activated dEGFR (dEGFR
l) and dp110
(dp110
CAAX) induced progressive accumulation of ,50-fold excess
glia (Figure 1A and 1B) [14,15]. dEGFR
l is a constitutively active
dEGFR variant in which a lambda dimerization domain replaces
the extracellular domain [14] (Figure S1). Co-overexpression of
combinations of dEGFR
l and core components of the PI3K
pathway, such as dAkt, induced phenotypes similar to repo.
dEGFR
l;dp110
CAAX, although phenotypes varied somewhat de-
pending on strength of pathway activation and transgene
expression (Figure S2 and Table S1). Dramatic glial overgrowth
also occurred upon co-overexpression of constitutively active dRas
(dRas85D
V12) or its effector dRaf (dRaf
gof) with dp110
CAAX, dAkt,
or a dPTEN
dsRNA, which partially knocked-down dPTEN (Figure
S2 and Table S1). Finally, glial overgrowth in repo.
dEGFR
l;dp110
CAAX larvae was strongly suppressed by co-overex-
pression of dPTEN or more moderately by dominant negative
dRas85D (dRas85D
N17) (Figure 1D and 1E), indicating that Ras
activity and excess phospho-inositols are essential for neoplasia.
In contrast, glial-specific activation of the EGFR-Ras pathway
alone, through overexpression of dEGFR
l or Raf
gof, induced 5–10
fold excess glia in the larval brain and later pupal lethality (Figure 1F
and Table S1). dRas85D
V12 overexpression induced approximately
5–10-fold excess glia, and these glia were smaller than wild-type or
dEGFR
l;dp110
CAAX glia. (Figure 1G). dRas85D
V12 may be more
potent than dEGFR
l because dRas85D
V12 can activate endogenous
PI3K signaling [16]. Overexpression of dEGFR
Elp, a classical
hypermorphic mutant form of dEGFR [17], induced excess glial
proliferation and neural morphogenesis defects (Figure S2), but also
caused early lethality which precluded examination of dEGFR
Elp-
dp110 interactions. As in mouse models, overexpression of wild-type
dEGFR failed to induce excess glia [6,17], and instead retarded CNS
growth (Figure S2). Unlike dEGFR
l,d E G F R
WT and dEGFR
Elp
have functional ligand-binding domains (Figure S1), and may cause
additional defects by sequestering ligand otherwise required for
normal development [17]. Glial-specific activation of the PI3K
pathway alone, either by overexpression of dp110
CAAX,
dp110
wild-type,d A k t ,o rd P T E N
dsRNA gave viable animals with
relatively normal brains (Figure 1H, Figure S2, and Table S1).
Therefore, coactivation of the EGFR and PI3K pathways synergize
to produce much more severe phenotypes than would be expected if
the effects of these pathways were additive.
In repo.dEGFR
l;dp110
CAAX brains, excess glia emerged in early
larval stages and accumulated over 5–7 days. dEGFR
l;dp110
CAAX
glia severely disrupt the normal cellular architecture of the larval
brain (Figure 1A and 1B and Figure 2A–C), lose normal stellate glial
morphologies (Figure 2A–C), and generate multilayered aggrega-
tions of abnormal glia throughout the brain (Figure 2A–C); in these
ways dEGFR
l;dp110
CAAX glia are neoplastic [18]. Like neoplastic
epithelial cells, dEGFR
l;dp110
CAAX glia ectopically expressed an
active form of the matrix metalloprotease dMMP1 (Figure S3),
which can confer an invasive potential [19,20], implying that
abnormal dEGFR
l;dp110
CAAX glia may be invasive within the
brain. Unlike neoplastic epithelia, neoplastic neural cells, such as
dEGFR
l;dp110
CAAX glia, typically retain expression of genes that
regulate neural cell fate, such as Repo [21,22].
Relativetocontrols,manydEGFR
l;dp110
CAAX glia showed BrdU
incorporation, which marks S-phase cells (Figure 2D and 2E),
indicating that neoplastic glia arise from overproliferation. repo.
dEGFR
l;dp110
CAAX animals also showed reduced BrdU in neuronal
precursors (Figure 2E,data not shown), demonstrating that neoplastic
glia disrupt neuronal development. The cell cycle is governed by
CyclinD-Cdk4 and CyclinE-Cdk2 complexes, which phosphorylate
and inactivate Rb proteins, to release E2F activators to stimulate G1-
Author Summary
Malignant gliomas, tumors composed of glial cells and
their precursors, are the most common and deadly human
brain tumors. These tumors infiltrate the brain and
proliferate rapidly, properties that render them largely
incurable even with current therapies. Mutations in genes
within the EGFR-Ras and PI3K signaling pathways are
common in malignant gliomas, although how these genes
specifically control glial pathogenesis is unclear. To
investigate the genetic basis of this disease, we developed
a glioma model in the fruit fly, Drosophila melanogaster.
We found that constitutive coactivation of the EGFR-Ras
and PI3K pathways in Drosophila glia gives rise to highly
proliferative and invasive neoplastic cells that create
transplantable tumor-like growths, mimicking human
glioma. This represents a robust cell-type-specific Dro-
sophila cancer model in which malignant cells are created
by mutations in genetic pathways thought to be driving
forces in a homologous human cancer. Genetic analyses
demonstrated that EGFR-Ras and PI3K induce fly glial
neoplasia through activation of a combinatorial genetic
network composed, in part, of other genetic pathways also
commonly mutated in human glioma. This network acts
synergistically to coordinately stimulate cellular prolifera-
tion, protein translation, and inappropriate migration.
Rate-limiting genes within this network may represent
important therapeutic targets in human glioma.
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dependent kinase inhibitors antagonize proliferation by inhibiting
CyclinE-Cdk2 and CyclinD-Cdk4, respectively. Cdc25 phosphatases
and mitotic cyclins, including CyclinB, promote G2-M progression.
Flies have single orthologs each for CyclinE, Cdk2, CyclinD, Cdk4,
CyclinB, and p21/p27/p57 (Dap), E2F activators (E2F1) and two
orthologs for Rb (Rbf1 and Rbf2) and Cdc25 (Stg and Twe) but no
Ink ortholog [23].
dEGFR
l;dp110
CAAX glia showed ectopic expression of dCy-
clinE and dCyclinB (Figure 2F–I), demonstrating that EGFR and
Figure 1. Coactivation of EGFR-Ras and PI3K in Drosophila glia causes neoplasia. (A) Optical projections of whole brain-ventral nerve cord
complexes from late 3
rd instar larvae approximately 130 hr AED, displayed at the same scale. Dorsal view; anterior up. Glia are labeled with CD8GFP
(green) driven by repo-Gal4. Each brain is composed of 2 symmetrical hemispheres attached to the ventral nerve cord (VNC). In
repo.dEGFR
l;dp110
CAAX larvae, both brain hemispheres and the VNC are enlarged and elongated relative to other genotypes. (B–H) 2 mm optical
sections of larval brain hemispheres from late 3
rd instar larvae approximately 130 hr AED, displayed at the same scale. 20 mm scale bars. Frontal
sections, midway through brains. Anterior up; midline to left. Glial cell nuclei are labeled with Repo (red). Glial cell bodies and membranes are labeled
with CD8GFP (green) driven by repo-Gal4.I nrepo.dEGFR
l;dp110
CAAX brains (B) there is a dramatic increase in number of glial nuclei relative to wild-
type (C), while in repo.dRas
N17;dEGFR
l;dp110
CAAX (D) and repo.PTEN; dEGFR
l;dp110
CAAX (E) brains there are fewer excess glial nuclei. In wild-type
animals (C), glia extend processes throughout the entire brain, enveloping nearly every cell with glial membranes. In contrast, dEGFR
l;dp110
CAAX glia
(B) show loss of fine projections and instead have compact cell bodies. Brains are counter-stained with anti-HRP (blue), which reveals neuronal fiber
tracts (neuropil) at high intensity and some cell bodies of neurons and neuronal precursors at low intensity. HRP staining varies slightly according to
exact plane of section, brain orientation, and mutant phenotype. Dark areas within brains contain unstained cells, which are typically optic lobe
neural precursors. Genotypes: (A) Clockwise from top left: repo-Gal4 UAS-CD8GFP/+, UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, UAS-
dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, UAS-dEGFR
l/+; repo-Gal4 UAS-CD8GFP/+, (B) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (C) repo-
Gal4 UAS-CD8GFP/+, (D) UAS-dEGFR
l UAS-dp110
CAAX/UAS-dRas85D
N17; repo-Gal4 UAS-CD8GFP/+, (E) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-PTEN/+; repo-
Gal4 UAS-CD8GFP/+, (F) UAS-dEGFR
l/+; repo-Gal4 UAS-CD8GFP/+, (G) repo-Gal4 UAS-CD8GFP/UAS-dRas85D
V12, (H) UAS-dp110
CAAX/+; repo-Gal4 UAS-
CD8GFP/+.
doi:10.1371/journal.pgen.1000374.g001
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PLoS Genetics | www.plosgenetics.org 3 February 2009 | Volume 5 | Issue 2 | e1000374Figure 2. Coactivation of EGFR and PI3K cell-autonomously promotes cell cycle entry. (A–F) Close-ups of late 3
rd instar larval brain
hemispheres. Anterior up; midline to left. 20 mm scale bars. (A–C) Glial cell nuclei are labeled with Repo (red). Glial cell bodies and membranes are
labeled with CD8GFP (green) driven by repo-Gal4. In wild-type (A), surface glia (SG) that cover the brain form a single-cell layer of fairly flat cells
whereas astrocyte-like cortex glia are often evenly spaced and form a honeycomb-like network of fine projections throughout the brain. Superficial
cortex glia show stellate morphology (arrowheads), and cortex glia deeper in the brain sometimes show a radial morphology (asterisk). In
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and progression. High-grade human gliomas contain highly
proliferative anaplastic glia and enlarged pleiomorphic polyploid
glia [24]. Similarly, repo.dEGFR
l;dp110
CAAX larvae showed
accumulation of small, highly proliferative glia that strongly
expressed cyclins and labeled with BrdU. repo.dEGFR
l;dp110
CAAX
larval brains also displayed abnormal polyploid glia, as assessed by
DAPI staining (data not shown), and these cells typically expressed
only dCyclinE but not dCyclinB, and thereby likely underwent
ectopic DNA replication without mitosis (Figure 2G and 2I, data
not shown). However, overexpression of dCyclinE-dCdk2, dCy-
clinD-dCdk4, or dE2F1-dDp complexes and/or Rbf1 knock-down
did not cause neoplasia, and instead either doubled glial cell
numbers or resulted in embryonic lethality (Figure S4, data not
shown).
We next examined negative regulators of the cell cycle.
dEGFR
l;dp110
CAAX glia expressed Rbf1, but showed little Dap, a
result we also observed in wild-type glia (Figure S5). Dap inhibits
dCyclinE-cdk2 complexes [25], and is transiently expressed in neural
progenitors to promote cell cycle exit as they begin differentiation
[26]. Dap overexpression completely suppressed repo.
dEGFR
l;dp110
CAAX glial overgrowth (Figure 2L), demonstrating that
glial neoplasia is cell-autonomous and requires dCyclinE-dCdk2.
Similarly, overexpressed Rbf1 and dCyclinE mutations also reduced
repo.dEGFR
l;dp110
CAAX glial overproliferation (Figure 2M, data not
shown). The gross neural morphogenesis defects observed in
repo.dEGFR
l;dp110
CAAX brains may be secondary to glial over-
proliferation since these defects were largely prevented by Dap or
Rbf1 co-overexpression (Figure 2J–M). In repo.dEGFR
l;dp110
CAAX
animals, other mutant glia outside of the brain, such as peripheral
glia, also became highly proliferative and invasive, and these defects,
too, were corrected by Rbf1 or Dap overexpression (data not shown).
In controls, Rbf1 or Dap overexpression in wild-type glia inhibited
proliferation (Figure S4), reducing numbers of glia by approximately
half.Together,these results suggest that repo-Gal4glia undergo at least
one round of cell division, consistent with published studies [27,28],
and this proliferation becomes prolonged by constitutive coactivation
of EGFR and PI3K signaling.
Coactivation of EGFR and PI3K Does Not Elicit Neoplasia
in All Neural Cell Types
The phenotype triggered by coactivation of EGFR and PI3K in
glia is distinct from other Drosophila brain-overgrowth mutant
phenotypes, which involve accretion of excess neurons or
neuroblasts [21,29]. repo.dEGFR
l;dp110
CAAX cells were not trans-
formed into neurons or neuroblasts as they lacked expression of the
Elav and Miranda markers (Figure S6). Lineage-tracing with a
Su(H)-lacZ neuroblast reporter showed that excess dEGFR
l;
dp110
CAAX glia did not express LacZ, and thus are not directly
derived from larval neuroblasts (data not shown). Moreover,
constitutive EGFR-Ras and PI3K signaling does not elicit
overgrowth in all neural cell types, as assessed with defined cell-
type specific Gal4-drivers (Table S2). For example, dRas85D
V12
overexpression in fly neurons causes defects in fate specification,
patterning, and apoptosis [30,31]. Co-overexpression of dEGFR
l
or dRas85D
V12 with dp110
CAAX in neurons (elav-Gal4, scratch-Gal4,
OK107-Gal4, and Appl-Gal4) and neuroblasts/neuronal precursors
(pros-Gal4, wor-Gal4, and 1407-Gal4) did not induce overgrowth
(Figure S7, data not shown), even with increased transgene
expression from Gal4 amplification [32]. In fact, broad co-
overexpression of dEGFR
l and dp110
CAAX in neuroblasts and
neuronal precursors (pros-Gal4) reduced brain size, perhaps because
signaling through these pathways stimulates precocious cell cycle
exit of neuronal precursors, as in the developing eye [33].
Furthermore, transient expression of dRas85D
V12 or dEGFR
l
and dp110
CAAX in embryonic glia (gcm-Gal4) also failed to promote
glial overgrowth (Figure S7) [27], demonstrating that sustained
activation of these pathways is required for glial overproliferation.
Certain glial subtypes, such as oligodendrocyte-like neuropil glia
(Eaat1-Gal4), some astrocyte-like cortex glia (Nrv2-Gal4), and
peripheral perineurial glia (gli-Gal4) also failed to become neoplastic
in response to EGFR-Ras and PI3K (Figure S7, data not shown)
[34–36]. Therefore, neoplastic proliferation is not a uniformcellular
response to EGFR and PI3K.
Coactivation of EGFR and PI3K Inhibits Cell Cycle Exit in
Glia
Since repo.dEGFR
l;dp110
CAAX animals die in 5–7 days, we
assessed the proliferative potential of mutant glia using an
abdominal transplant assay, a classic test of tumorigencity in flies
[37]. Brain fragments from repo.dEGFR
l;dp110
CAAX and wild-type
larvae were transplanted into young adults. Wild-type transplants
grew and survived over 1–6 weeks, but produced few glia
(Figure 3A and 3C). dEGFR
l;dp110
CAAX mutant glia survived
and proliferated into massive tumors that filled the hosts’
abdomens, often causing premature death (Figure 3B). Tumors
were composed of small glial cells with little cytoplasm (Figure 3D–
F). Tumors also contained trachea embedded throughout their
mass (Figure 3D and 3E and Video S1), suggesting that tumors
stimulated growth of new trachea or enveloped existing trachea,
perhaps in a process akin to tumor angiogenesis. The leading
edges of the tumors harbored individual cells invading nearby
repo.dEGFR
l;dp110
CAAX brains (B,C) surface glia (SG) and superficial cortex glia (brighter GFP, arrowheads) form thick multicellular aggregations
throughout the brain and often adopt a spindle-shaped morphology (arrowheads). In repo.dEGFR
l;dp110
CAAX brains, deeper cortex glia (C) can still
form fine projections, but more often lack these and create loose aggregates of abnormally shaped cells (asterisks). (D,E) BrdU labeling (red) of S-
phase cells. The prominent replicative cells in normal brains (D) are neuroblasts (‘NB’) and optic lobe neural precursors (‘NP’), identified by their
stereotyped position and/or staining for HRP (faint blue). The prominent replicative cells in repo.dEGFR
l;dp110
CAAX brains (E) are glia (‘G’), which do
not stain for HRP. 2 mm optical sections. (F–I) dCyclinE (F,G) and dCyclinB (H,I) expression (red) shown alone (left panels) and with Repo (blue nuclei)
and CD8GFP (green, membranes/cytoplasm) glial markers (right in each panel). ‘G’ denotes representative glia, ‘NB’, representative neuroblasts. In
wild-type (F, H), glia rarely expressed dCyclinE or dCyclinB, while neuroblasts (‘NB’) showed predominant expression. dCyclinE expression is primarily
nuclear in dEGFR
l;dp110
CAAX glia (G), visible as purple in overlay (right panel), although not all mutant glia express dCyclinE. Inset in (G) shows
dCyclinE expression in polyploid glia (‘ppG’). (I) dCyclinB expression in dEGFR
l;dp110
CAAX glia is primarily cytoplasmic, visible as yellow in overlay
(right panel). ppG in repo.dEGFR
l;dp110
CAAX brains do not express dCyclinB, as seen by the absence of yellow or purple in overlay. (F,G) 6.5 mm and
(H,I) 5 mm optical projections. (J–M) 2 mm optical sections of larval brain hemispheres from late 3
rd instar larvae approximately 130 hr AED, displayed
at the same scale. Frontal sections, midway through brains. repo.dEGFR
l;dp110
CAAX brains (K) show a dramatic increase in number of glial nuclei (red)
relative to wild-type (J). Glial cell nuclei are decreased by co-overexpression of Dap (L) or Rbf1 (M) with dEGFR
l;dp110
CAAX. Glial cell bodies and
membranes (green, repo.CD8GFP reporter) appear relatively normal in (L) and (M) compared to (J). HRP counter-stain (blue) reveals neuropil at high
intensity and neuronal cell bodies at low intensity. Genotypes: (A), (D), (F), (H), and (J) repo-Gal4 UAS-CD8GFP/+, (B), (C), (E), (G), (I), and (K) UAS-dEGFR
l
UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (L) UAS-dEGFR
l UAS-dp110
CAAX/UAS-dap; repo-Gal4 UAS-CD8GFP/+, (M) UAS-dEGFR
l;UAS-dp110
CAAX/+; repo-
Gal4 UAS-CD8GFP/UAS-Rbf1.
doi:10.1371/journal.pgen.1000374.g002
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consistent with the ectopic expression of active dMMP1 observed
in dEGFR
l;dp110
CAAX glia in the larval brain (Figure S3).
However, some tissues, such as the gut, did not contain metastases,
implying some degree of selective invasion. Thus, once uncon-
strained by the larval life cycle, dEGFR
l;dp110
CAAX glia fail to
exit the cell cycle, continue to proliferate, and form highly invasive
tumors, all properties of human cancer cells.
Figure 3. Coactivation of EGFR and PI3K inhibits cell cycle exit in glia. Larval brain fragments of the indicated genotypes were injected into
the abdomens of wild-type adult hosts and grown for 3 weeks. CD8GFP (green) labels all transplanted glia within each graft. Actin (red, phalloidin)
reveals abdominal anatomy. (A, B) Representative frozen sections of whole abdomens with wild-type (A) or dEGFR
l;dp110
CAAX (B) transplants, shown
at the same scale. 50 mm optical projections; 100 mm scale bars. (C–F) Transplants shown at higher magnification. dEGFR
l;dp110
CAAX transplants (D–
F) are rich with glial cell nuclei (Repo, in blue) relative to wild-type transplants (C). Asterisks indicate trachea embedded in dEGFR
l;dp110
CAAX
transplants (D,E), visible as hollow actin-positive (red) tubules running through tissues. Arrowheads in (F) indicate dEGFR
l;dp110
CAAX glial cells
invading an ovary, distinguished by its characteristic actin staining (red). 1–1.5 mm optical sections; 20 mm scale bars. Genotypes: All hosts were w
1118
virgin females. Transplanted glia as follows: (A) and (C) UAS-CD8GFP/+; repo-Gal4/+, (B), (D), (E), and (F) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-CD8GFP/+;
repo-Gal4/+.
doi:10.1371/journal.pgen.1000374.g003
A Drosophila Model for Glioma
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Neoplastic Glia
To explore the invasive potential of mutant glia, we used FLP-
FRT clonal analysis, a technique in which discrete clones of
mutant cells are induced in otherwise normal tissues, a situation
analogous to somatic tumorigenesis. We used a heat-shock-driven
FLP-recombinase to catalyze mitotic recombination between
FRT-bearing chromosomes such that a daughter cell (and all of
its clonal progeny) initiated expression of GFP and UAS-
containing transgenes only in repo-Gal4-expressing cells [12].
Clones were induced late in development, from mitotic founder
cells, and were examined in adults. We could not definitively
determine if clones were derived from single cell events since our
study of these clones was retrospective, but given the frequency of
control clone induction, many mutant clones likely originated from
single cells.
In wild-type controls, we observed clones in 68% of brains
examined (N=149). Of the brains with clones, 75% had 1–3
clones, and 83% of these clones consisted of 1–3 cells of the same
glial subtype (Figure 4A and 4B). Glial clones overexpressing
dRas85D
V12, dEGFR
l, or dEGFR
Elp alone typically contained 2-
fold more cells than wild-type (dRas85D
V12 shown in Figure 4C).
To examine PI3K signaling, we used a dPTEN null allele, which
became homozygous in FLP-FRT clones. dPTEN
2/2 glia did not
overgrow, but did show aberrant cytoplasmic projections
(Figure 4D), perhaps reflecting dPTEN function in the cytoskel-
eton [38].
To coactivate EGFR-Ras and PI3K in glial clones,
dRas85D
V12, dEGFR
Elp, or dEGFR
l was overexpressed within
dPTEN
2/2 glia, using repo-Gal4. We observed overgrown and
invasive dRas85D
V12;dPTEN
2/2 and dEGFR
Elp;dPTEN
2/2 clones
(Figure 4E–G). dEGFR;dPTEN
2/2 clones were less affected
(Figure 4F and 4G), consistent with the larval overexpression of
dRas85D
V12 giving more severe growth phenotypes. Tumor-like
overgrowth was only observed in dEGFR-dRas85D;dPTEN
2/2
cells, illustrating that chronic EGFR-Ras activation and PTEN
loss can cause cell-autonomous over-proliferation. Cells from these
double mutant clones appeared to invade the brain, typically
following fiber tracts, and sometimes induced the formation of
trachea (Figure 4E). Tumor-like growths of dEGFR-dRas85D;dP-
TEN
2/2 cells often penetrated deep into the brain, as exemplified
by Videos S3 and S4 which show an animated 88 mm thick
confocal z-stack of the dRas85D
V12;dPTEN
2/2 clone in Figure 4E
compared to a 16 mm thick z-stack of a wild-type control clone in
Figure 4A. These phenotypes were reminiscent of invasion and
angiogenesis in human gliomas [24]. We more commonly
observed smaller dEGFR-dRas85D;dPTEN
2/2 clones composed
of relatively differentiated, enlarged glia with diffusely invasive
projections (Figure 4G); these clones likely derive from glia that
differentiated prior to achieving sufficient EGFR-Ras transgene
expression, and are consistent with findings that not all glial
subtypes become neoplastic.
Since neoplastic larval glia were concentrated in the outer
anterior central brain and developing optic lobe, they may be
derived from glial progenitor cells present in these regions
[27,28,39]. To create clones from a discrete subpopulation of
glial progenitors, we used an eyeless(ey)-promoter driven FLP-
recombinase (ey-FLP), which is active in ey-expressing glial
progenitors in the optic lobe [27]. Single mutant ey-FLP clones
of dPTEN
2/2, dRas85D
V12, or dEGFR
Elp cells contained a
modest number of excess and abnormal glia relative to wild-type
controls (Figure 4H–J and Figure S8). In contrast, the double
mutant dRas85D
V12;dPTEN
2/2, dEGFR
Elp;dPTEN
2/2,o r
dEGFR
l;dPTEN
2/2 ey-FLP clones, which emerge as approxi-
mately tens of cells in 3
rd instar larval brains (Figure 4K), became
large invasive tumors composed of hundreds to thousands of cells
in adults (Figure 4L and Figure S8).
EGFR;PI3K Induces Glial Neoplasia via Pnt and Stg
Expression
To address the function of EGFR-Ras and PI3K in glioma, we
analyzed the genetic basis of glial pathogenesis in our repo.
dEGFR
l;dp110
CAAX model, as this model shows robust neoplasia,
similarity to human tumor genotypes, and sensitivity to dEGFR
and dPTEN gene dosage (data not shown).
EGFR-Ras signaling can promote proliferation through Erk
kinase-mediated induction of nuclear targets. In repo.
dEGFR
l;dp110
CAAX brains, mutant glia showed high levels of
nuclear, activated di-phospho-Erk relative to wild-type glia in
control brains (Figure 5A and 5B). In flies, Erk activity can induce
expression of PntP1, an ETS-family transcription factor encoded
by the pointed (pnt) locus [40,41]. PntP1, which is expressed in
embryonic glia and is required for their normal development [40],
was upregulated in dEGFR
l;dp110
CAAX glia (Figure 5C and 5D).
High levels of PntP1 can be detected normally in neuronal
progenitors (data not shown), suggesting that it promotes a
proliferative progenitor state. In developing eye tissue, EGFR-Ras-
Erk signaling induces Pnt proteins to stimulate G2-M cell cycle
progression through direct upregulation of Stg (Cdc25 ortholog)
expression [41]. Glial-specific RNAi knock down of pnt reduced
Stg expression and completely suppressed dEGFR
l;dp110
CAAX
neoplasia (Figure 5E–H), demonstrating that Pnt proteins are
required for both Stg expression and neoplastic overproliferation
in dEGFR
l;dp110
CAAX glia. Notably, in repo.pnt
dsRNA;
dEGFR
l;dp110
CAAX brains, glia maintained their fate, as evidenced
by repo-Gal4 and Repo expression.
Stg itself was rate limiting for glial neoplasia. Reduction of stg
with a mutation or a stg
dsRNA partially suppressed the repo.
dEGFR
l;dp110
CAAX phenotype, whereas overexpressed Stg syner-
gistically enhanced neoplasia (Figure 5E and Figure S9, data not
shown). In contrast, Stg overexpression alone increased glial cell
numbers approximately 2-fold, and could not induce neoplasia
when combined with PI3K effectors (data not shown). Thus,
dEGFR
l;dp110
CAAX induces neoplasia via coordinated stimula-
tion of G1-S entry through dCyclinE, and G2-M progression
through Stg, both of which are EGFR-Ras dependent outputs
[41,42].
EGFR;PI3K Glial Neoplasia Requires Akt and Tor
Activation and FoxO Inactivation
We sought to determine which PI3K effectors contribute to the
repo.dEGFR
l;dp110
CAAX phenotype. Genetic reduction of dAkt, a
major target of PI3K signaling, with a dAkt
dsRNA or a mutant allele
strongly suppressed repo.dEGFR
l;dp110
CAAX glial neoplasia
(Figure 6A–C, data not shown). Therefore, Akt is necessary for
the outcome of EGFR-PI3K coactivation. Many Akt effectors are
implicated in glioma, and we tested orthologs of these loci in our
model (Table S3).
Tor, a kinase that promotes cell growth and proliferation, is a
key Akt target. In glioma models, coactivation of EGFR-Ras and
PI3K stimulates Tor, and in humans, Tor activity is correlated
with poor patient prognosis [43,44]. We tested the single Drosophila
Tor ortholog, dTor, by genetically reducing dTor activity in
repo.dEGFR
l;dp110
CAAX larvae with a viable combination of
hypomorphic dTor alleles or by co-overexpression of dominant
negative dTor [45,46]. Both of these manipulations reduced glial
overgrowth (Figure 6D, data not shown).
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PLoS Genetics | www.plosgenetics.org 7 February 2009 | Volume 5 | Issue 2 | e1000374Figure 4. Coactivation of EGFR-Ras and PI3K creates invasive neoplastic glia. FLP/FRT clones of repo-Gal4-expressing glia within whole
adult brains, all displayed at the same scale. CD8GFP (green) labels the cell bodies and membranes of glial clones derived by FLP/FRT mitotic
recombination (see text). Repo (red) labels all glial cell nuclei, in both clones and surrounding normal tissue. Red flare is background flourescencei n
(C–F). Frontal sections; anterior up; midline to left. 20 mm scale bars. (A–G) hs-FLP clones from approximately 2 week-old adults, heat-shocked as late
pupae or young adults. (A–B) GFP-positive wild-type control clones composed of 1–3 cells with normal stellate morphology. (C) a dRas85D
V12-
expressing clone in the same brain region as (D,E). dRas85D
V12 clones typically display the most proliferation among single mutant clones, containing
approximately 2–56 more cells than controls. (D) a dPTEN
2/2 clone with abnormal morphology and punctate membrane-bound CD8GFP. (E) a
dRas85D
V12; PTEN
2/2 double mutant clone, composed of hundreds of cells that have overtaken the optic lobe and invaded the central brain (arrow),
extending through the entire depth of the brain (Video S3). Asterisks demark optically opaque tracheal branches. (F,G) dEGFR
l;dPTEN
2/2 and
dEGFR
Elp;dPTEN
2/2 clones, which typically have less cellular density than dRas85D
V12; PTEN
2/2 clones. 5–10 mm optical projections. (H–L) ey-FLP
clones derived from a population of ey-FLP and repo-Gal4-expressing mitotic cells. (H–J,L) 8.5 mm confocal optical projections of whole optic lobes
from brains of similarly aged adults. Both dRas85D
V12 (I) and dPTEN
2/2 (J) clones contain 2–5-fold more cells than wild-type controls (H). dRas85D
V12;
PTEN
2/2 double mutant clones (L) form large glial tumors. White-bordered cut-out shows the high density of glial cell nuclei (red) in dRas85D
V12;
PTEN
2/2 double mutant clones (L). (K) shows an earlier stage dRas85D
V12; PTEN
2/2 clone in the larval brain, where dRas85D
V12; PTEN
2/2 clones begin
as clusters of tens of cells, and grow to become large clones of hundreds of cells by early adulthood, as in (L). Genotypes: (A) and (B) hs-flp1/+;FRT
G13
tubGal80/FRT
G13 UAS-CD8GFP; repo-Gal4/+, (C) hs-flp1/+; FRT
G13 tubGal80/FRT
G13 UAS-CD8GFP; repo-Gal4/UAS-dRas85D
V12, (D) hs-flp1/+; FRT
40A
tubGal80/FRT
40A PTEN
2L117; repo-Gal4 UAS-CD8GFP/+, (E) hs-flp1/+; FRT
40A tubGal80/FRT
40A PTEN
2L117; repo-Gal4 UAS-CD8GFP/UAS-dRas85D
V12, (F) hs-
flp1/+; FRT
40A tubGal80/FRT
40A PTEN
2L117; repo-Gal4 UAS-CD8GFP/UAS-dEGFR
l, (G) hs-flp1/+; FRT
40A tubGal80/FRT
40A PTEN
2L117; repo-Gal4 UAS-CD8GFP/
UAS-dEGFR
Elp, (H) ey-flp/+; FRT
40A tubGal80/FRT
40A; repo-Gal4 UAS-CD8GFP/+, (I) ey-flp/+; FRT
G13 tubGal80/FRT
G13 UAS-CD8GFP; repo-Gal4/UAS-
dRas85D
V12, (J) ey-flp/+; FRT
40A tubGal80/FRT
40A PTEN
2L117; repo-Gal4 UAS-CD8GFP/+, (K and L) ey-flp/+; FRT
40A tubGal80/FRT
40A PTEN
2L117; repo-Gal4
UAS-CD8GFP/UAS-dRas85D
V12.
doi:10.1371/journal.pgen.1000374.g004
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PLoS Genetics | www.plosgenetics.org 8 February 2009 | Volume 5 | Issue 2 | e1000374In flies and mammals, Tor exists in two different signaling
complexes, TORC1 and TORC2. TORC2, a complex including
Tor and the Sin1 and Rictor regulatory proteins, directly
phosphorylates Akt, creating a positive feedback loop that fully
activates Akt [47]. In mouse, Sin1 and Rictor mutants die early due
to extraembryonic defects, but dSin1 and dRictor mutant flies are
viable as homozygous nulls, allowing us to remove TORC2
function genetically [47,48]. dSin1
2/2; repo.dEGFR
l;dp110
CAAX
larval brains showed a near-wild type phenotype (Figure 6E).
Results were similar with a dRictor null allele and a dSin1
dsRNA (data
not shown). dSin1
2/2 and dRictor
2/2 mutants display reduced Akt-
dependent phosphorylation and inactivation of dFoxO [49], the
single Drosophila ortholog of FoxO transcription factors. This
suggests that TORC2 loss might antagonize glial neoplasia
Figure 5. EGFR;PI3K induces glial neoplasia via Pnt and Stg expression. (A–D,F–H) late 3
rd instar larval brain hemispheres. Staining patterns
are shown alone (left panels) and with overlaid repo-Gal4-driven CD8GFP (green) and/or Repo (blue) glial markers (right panels). Close-ups of medial
anterior regions; anterior up; midline to left. 20 mm scale bars. (A,B): Diphospho-ERK (P-ERK, red) staining in wild-type (A) and repo.dEGFR
l;dp110
CAAX
(B) brains. High levels of nuclear ERK (arrows) are present in dEGFR
l;dp110
CAAX glia, but not in wild-type glia. Glial cell bodies are labeled green in
overlay (right panels). 2 mm optical sections. (C,D): PntP1 expression (red) in wild-type (C) and repo.dEGFR
l;dp110
CAAX (D) brains. Intense PntP1
expression in dEGFR
l;dp110
CAAX glial nuclei (arrows) is coincident with Repo and visible as purple nuclei in overlay (D, right panel). 3 mm optical
projections. (E) Optical projections of whole brain-ventral nerve cord complexes from late 3
rd instar larvae of the indicated genotype, approximately
130 hr AED, all matched in scale. CD8GFP (green) expression in all repo-Gal4-expressing glia reveals structure of the entire CNS. 200 mm scale bar. (F–
H): Stg expression (red) in wild-type (F), repo.dEGFR
l;dp110
CAAX (G), and repo.pnt
dsRNA;dEGFR
l;dp110
CAAX (H) brains. Stg expression in glia is visible as
purple nuclei in overlay (right panels). repo.pnt
dsRNA;dEGFR
l;dp110
CAAX glia (H) show reduced Stg compared to repo.dEGFR
l;dp110
CAAX glia (G,
arrows indicate some Stg-expressing glia). Intense Stg expression (red only) in neuroblasts (‘NB’) and ganglion mother cell neuronal progenitors (‘NP’)
is visible in all panels. Stg is visualized with the stg
CB03726 protein trap, a viable stg allele that contains a GFP-expressing exon [68] and reflects the
observed patterns of endogenous stg expression (data not shown). 5 mm optical projections. Genotypes: (A), (C), and (F) repo-Gal4 UAS-CD8GFP/+, (B),
(D), and (G) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (E) from left to right: repo-Gal4, UAS-CD8GFP/+, UAS-dEGFR
l UAS-dp110
CAAX/+;
repo-Gal4 UAS-CD8GFP/+, UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-pnt
dsRNA, UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/
stg
01235, UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-stg/+; repo-Gal4 UAS-CD8GFP/+, (F) stg
CB03726/repo-Gal4 UAS-CD8GFP, (G) UAS-dEGFR
l UAS-dp110
CAAX/+;
stg
CB03726/repo-Gal4 UAS-CD8GFP, (H) UAS-dEGFR
l UAS-dp110
CAAX/+; stg
CB03726 UAS-pnt
dsRNA/repo-Gal4 UAS-CD8GFP.
doi:10.1371/journal.pgen.1000374.g005
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PLoS Genetics | www.plosgenetics.org 9 February 2009 | Volume 5 | Issue 2 | e1000374Figure 6. EGFR;PI3K glial neoplasia requires Akt and Tor activation and FoxO inactivation. 2 mm optical sections of larval brain
hemispheres from late 3
rd instar larvae, all approximately 130 hr AED, displayed at the same scale. 20 mm scale bars. Frontal sections, midway
through brains. Anterior up; midline to left. Glial cell nuclei are labeled with Repo (red); glial cell bodies and membranes are labeled with CD8GFP
(green) driven by repo-Gal4. An anti-HRP counter-stain (blue) reveals neuropil (neuronal fibers) at high intensity and neuronal cell bodies at low
intensity. HRP staining can vary slightly according to exact plane of section and brain orientation. repo.dAkt
dsRNA;dEGFR
l;dp110
CAAX (C),
repo.dTor
TED;dEGFR
l;dp110
CAAX (D), dSin1
2/2;repo.dEGFR
l;dp110
CAAX (E), repo.dRaptor
dsRNA;dEGFR
l;dp110
CAAX (I), repo.dS6K
dsRNA;dEGFR
l;dp110
CAAX
(J), repo.deIF4E
dsRNA;dEGFR
l;dp110
CAAX (K), and repo.d4EBP;dEGFR
l;dp110
CAAX (L) brains showed near normal (B) numbers of glial nuclei (red) relative
to repo.dEGFR
l;dp110
CAAX brains (A). repo.dFoxO
SA;dEGFR
l;dp110
CAAX (F) shows partial reduction in number of glial nuclei (red) relative to
repo.dEGFR
l;dp110
CAAX brains (A). repo.dTSC1
dsRNA;dEGFR
l;dp110
CAAX brains (H) show increased numbers of glial nuclei relative to
repo.dEGFR
l;dp110
CAAX brains (A). dSin1
2/2 (G) brains displayed normal numbers of glia (B). Genotypes: (A) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-
lacZ
nls/+; repo-Gal4 UAS-CD8GFP/+, (B) repo-Gal4 UAS-CD8GFP/+, (C) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-dAkt
dsRNA, (D) UAS-
dEGFR
l UAS-dp110
CAAX/+; UAS-dTor
TED/+; repo-Gal4 UAS-CD8GFP/+, (E) UAS-dEGFR
l UAS-dp110
CAAX/+; dSin1
e03756/l(2)Bsc11; repo-Gal4 UAS-CD8GFP/+, (F)
UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-dFoxO
SA/+; repo-Gal4 UAS-CD8GFP/+, (G) dSin1
e03756/l(2)Bsc11; repo-Gal4 UAS-CD8GFP/+, (H) UAS-dEGFR
l UAS-
dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-dTSC1
dsRNA, (I) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-dRaptor
dsRNA/+; repo-Gal4 UAS-CD8GFP/+, (J) UAS-dEGFR
l
UAS-dp110
CAAX/UAS-dS6K
dsRNA; repo-Gal4 UAS-CD8GFP/+, (K) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-deIF4E
dsRNA, (L) UAS-dEGFR
l
UAS-dp110
CAAX/+; UAS-d4EBP/+; repo-Gal4 UAS-CD8GFP/+.
doi:10.1371/journal.pgen.1000374.g006
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SA, which is
resistant to dAkt phosphorylation [45], only partially suppressed
repo.dEGFR
l;dp110
CAAX glial overproliferation (Figure 6F), argu-
ing that TORC2 has additional roles. Notably, on their own,
dSin1
2/2 and dRictor
2/2 mutant flies did not show any detectable
glial defects (Figure 6G, data not shown). Thus, TORC2 is
dispensible for normal glial development, but is necessary for
dEGFR
l;dp110
CAAX glial neoplasia.
TORC1, a complex including Tor and the Raptor regulatory
protein, drives cellular growth by stimulating protein synthesis
through its effectors S6 kinase and the eIF-4E translation initiation
factor [47]. Akt and Erk stimulate TORC1 through phosphory-
lation and inactivation of the TSC1-TSC2 protein complex, which
activates Rheb, and stimulates TORC1 kinase activity. We tested
TORC1 function by glial-specific overexpression of dsRNAs for
the single Drosophila orthologs of Raptor (dRaptor), S6-kinase
(dS6K), and eIF4E (deIF4E); these all significantly reduced
accumulation of dEGFR
l;dp110
CAAX mutant glial cells, but only
caused mild glial hypoplasia in controls (Figure 6I–K and Figure
S10). Co-overexpression of d4EBP, a deIF4E antagonist and
dFoxO target gene, also blocked glial neoplasia (Figure 6L). Glial-
specific RNAi of dTSC1 enhanced repo.dEGFR
l;dp110
CAAX glial
overgrowth (Figure 6H). However, overexpression of
dTSC1
dsRNA, dRheb, activated dS6K (dS6K
act), or deIF4E alone
did not produce glial overproliferation, even though these
constructs can mimic TORC1 activation (Figure S10, data not
shown) [47,49]. Thus, TORC1 activity is necessary for EGFR-
PI3K-driven glial neoplasia, but is not sufficient. Moreover,
neither deIF4E nor dS6K
act produced glial neoplasia when co-
overexpressed with dEGFR
l (data not shown), illustrating that
additional dTor-dependent outputs synergize with dEGFR
signaling to drive neoplasia.
Myc and Max Drive EGFR;PI3K Glial Neoplasia via CyclinD-
Cdk4
dTor coordinates increased translation, mediated by dS6K and
deIF4E, with expression of cell cycle regulators and ribosomal
components, through dMyc, the single Drosophila ortholog of the
Myc bHLH transcription factors [49]. Within developing
epithelial tissues, dMyc is required for TORC1-dependent growth
and can substitute for dTor activity [49,50]. Myc protein levels can
also be posttranslationally upregulated by EGFR-Ras-Raf signal-
ing [16,51]. Thus, we suspected that dMyc might mediate signal
integration between EGFR-Ras and PI3K.
dEGFR
l;dp110
CAAX glia showed high levels of nuclear dMyc
compared to wild-type glia (Figure 7A and 7B). dMyc was also
highly expressed in wild-type neuroblasts (Figure 7A), suggesting
that dMyc promotes a proliferative progenitor state [21]. Genetic
reduction of dMyc with a dsRNA or a single loss-of-function allele
strongly suppressed dEGFR
l;dp110
CAAX glial neoplasia
(Figure 7D, data not shown). In fact, some dMyc
+/2; repo.
dEGFR
l;dp110
CAAX animals were rescued to viability, indicating
that dMyc is an essential rate-limiting output of EGFR-PI3K
coactivation.
Myc proteins activate transcription through heterodimerization
with the bHLH Max. Max activity was also required for glial
neoplasia; a dsRNA for dMax, the single Drosophila Max ortholog,
strongly suppressed repo.dEGFR
l;dp110
CAAX overgrowth
(Figure 7E). dMyc-dMax heterodimers promote proliferation by
activating expression of multiple cell cycle genes, including
dCyclinD and dCdk4 [52]. dCyclinD expression, which is high
in repo.dEGFR
l;dp110
CAAX glia, was inhibited by a dMyc
dsRNA
(Figure 7F–H), suggesting that dMyc reduction suppresses glial
neoplasia through reduced dCyclinD-dCdk4 activity. To test this
we used loss-of-function mutations in dCdk4, which are viable
[23]. dCdk4
2/2; repo.dEGFR
l;dp110
CAAX larvae showed near
complete absence of excess glia and rescue of glial morphogenesis
defects (Figure 7I). Moreover, a dCdk4
dsRNA and dCyclinD
dsRNA
suppressed repo.dEGFR
l;dp110
CAAX (data not shown). Thus,
dCyclinD-dCdk4 is essential for EGFR-PI3K glial neoplasia,
although dCdk4 is not required for development (Figure 7J).
Myc Overexpression or Rb Loss Synergizes with EGFR
dMyc is necessary for glial neoplasia, but is not sufficient when
overexpressed alone (Figure 8C). dMyc-overexpressing glia
showed polyploidy (Figure 8C, data not shown), indicating that
these cells undergo DNA replication without mitosis, but require
additional signals for cell cycle progression. In contrast, co-
overexpression of dMyc with dEGFR
l produced a phenotype on
par with that of repo.dEGFR
l;dp110
CAAX (Figure 8D), indicating
that dMyc overexpression can substitute for PI3K activation and
promote neoplasia when combined with EGFR signaling.
Given that the dMyc targets dCyclinD-dCdk4 are required for
dEGFR
l;dp110
CAAX neoplasia, we tested whether dCyclinD-
dCdk4 overexpression could cooperate with dEGFR
l. Addition-
ally, we tested loss of Rbf1, the only known dCdk4 substrate that
controls proliferation [23]. repo.dCyclinD;dCdk4;dEGFR
l and
repo.Rbf1
dsRNA;dEGFR
l animals showed glial overgrowth, but did
not accumulate as many cells as repo.dEGFR
l;dp110
CAAX animals
(Figure 8E and 8F). Thus, glia likely require additional dp110 or
dMyc effectors to undergo full neoplastic proliferation. Other
known PI3K and dMyc-dMax target genes that promote
proliferation include ribosomal proteins and translation regulators
[49,52], such as eIF4E, which is highly expressed in
dEGFR
l;dp110
CAAX glia and required for neoplasia (Figure 6
and Figure S11).
Our data imply that PI3K, dMyc, and dCyclinD-dCdk4 exist in
a linear system, in which Rbf1 inactivation by dCyclinD-dCdk4 is
one direct output of dp110
CAAX or dMyc. However, in high-grade
glioma, Rb loss co-occurs with EGFR and PTEN mutations [2],
implying that these mutations cooperate to promote gliomagen-
esis. To explore interactions between Rb and EGFR-PI3K, we
created the triple mutant repo.Rbf1
dsRNA;dEGFR
l;dp110
CAAX.
These animals displayed exacerbated glial neoplasia, with a
substantial increase in small anaplastic-like glia throughout the
CNS (Figure 8G). This synergistic interaction likely derives from
derepression of dE2F1 upon Rbf1 loss, and concomitant increased
expression of dE2F1 target genes, including Stg and dCyclinE
[53]. Increased dCyclinE and Stg expression may accelerate cell
cycle progression, perhaps through increased dCdk2 and dCdk1
activity and/or truncated G1 and G2 gap phases caused by
constant dCyclinE and Stg protein levels [23]. Consistent with
this, we observed increased dCyclinE expression in Rbf1
dsRNA;
dEGFR
l;dp110
CAAX glia relative to dEGFR
l;dp110
CAAX glia
(Figure 8H and 8I), and co-overexpression of Stg or dCyclinE-
dCdk2 with dEGFR
l;dp110
CAAX synergistically exacerbated glial
neoplasia, yielding phenotypes similar to repo.Rbf
dsRNA;
dEGFR
l;dp110
CAAX (Figure 5E and Figure S9, data not shown).
To assess dCdk2 activity in repo.Rbf1
dsRNA;dEGFR
l;dp110
CAAX
brains compared to repo.dEGFR
l;dp110
CAAX brains, we stained for
phospho-MPM2 (Figure S12), which detects nuclear foci in cells
with active dCyclinE-dCdk2 complexes [54]. Phospho-MPM2 foci
were present in glia of both genotypes, although repo.Rbf1
dsRNA;
dEGFR
l;dp110
CAAX brains appeared to have a higher density of glia
with phospho-MPM2 foci (Figure S12), suggesting that expanded
expression of dCyclinE results in broader activation of dCdk2.
Thus, while PI3K and Rbf1 act in a common genetic pathway
linked by dCyclinD-dCdk4, Rbf1 loss nevertheless synergizes with
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PLoS Genetics | www.plosgenetics.org 11 February 2009 | Volume 5 | Issue 2 | e1000374Figure 7. Myc and Max are required to drive EGFR;PI3K glial neoplasia via CyclinD-Cdk4. Frontal sections of 3
rd instar larval brains.
Anterior up; midline to left. 20 mm scale bars. (A,B) Myc expression (red) in medial anterior regions of wild-type (A) and repo.dEGFR
l;dp110
CAAX brains
(B). dMyc labeling (red) is shown alone (left) and with overlaid Repo (blue) and CD8GFP (green) glial markers (right). dMyc is highly expressed in
neuroblasts (‘NB’) and moderately expressed in ganglion mother cell neuronal progenitors (‘NP’) in both genotypes. Relative to wild-type (A),
repo.dEGFR
l;dp110
CAAX brains (B) have high levels of dMyc in glia (‘G’), visible as purple nuclei in overlay (B, right panel). 4.5 mm optical projections.
(C–E,I,J) 2 mm optical sections midway through larval brain hemispheres from late 3
rd instar larvae, displayed at the same scale. Repo (red) labels glial
cell nuclei. repo.CD8GFP reporter (green) labels glial cell bodies and membranes. HRP (blue) reveals neuropil at high intensity and neuronal cell
bodies at low intensity. dMyc
+/2; repo.dEGFR
l;dp110
CAAX (D), repo.dMax
dsRNA;dEGFR
l;dp110
CAAX (E), and dCdk4
2/2; repo.dEGFR
l;dp110
CAAX (I) brains
have decreased numbers of glia compared to repo.dEGFR
l;dp110
CAAX (C). (J) dCdk4
2/2 larval brains have normal gross morphology and glial cell
numbers. (F–H) dCyclinD expression (red) overlaid with Repo expression (blue). repo.dEGFR
l;dp110
CAAX brains (G) show increased dCyclinD (red)
compared to wild-type (F). dCyclinD expression decreases when dMyc is knocked-down in repo.dMyc
dsRNA;dEGFR
l;dp110
CAAX brains (H). 11 mm
optical projections. Genotypes: (A) repo-Gal4 UAS-CD8GFP/+, (B) and (C) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (D) dMyc
P0/+/UAS-
dEGFR
l UAS-dp110
CAAX; repo-Gal4 UAS-CD8GFP/+, (E) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-dMax
dsRNA/+; repo-Gal4 UAS-CD8GFP/+, (F) repo-Gal4, UAS-
GFP
nls/+, (G) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-GFP
nls/+, (H) UAS-dEGFR
l UAS-dp110
CAAX/+; UAS-dMyc
dsRNA/+; repo-Gal4 UAS-GFP
nls/+, (I) UAS-
dEGFR
l UAS-dp110
CAAX/+; dCdk4
3/k06503; repo-Gal4 UAS-CD8GFP/+, (J) dCdk4
3/k06503; repo-Gal4 UAS-CD8GFP.
doi:10.1371/journal.pgen.1000374.g007
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and this synergy emerges from increased expression of dCyclinE
and Stg, rate-limiting regulators of the cell cycle.
Discussion
We show that constitutive coactivation of EGFR-Ras and PI3K
signaling in Drosophila glia and glial precursors gives rise to
neoplastic, invasive cells that create transplantable tumor-like
growths, mimicking human glioma, and mirroring mouse glioma
models. This represents a robust organotypic and cell-type specific
Drosophila cancer model in which malignant cells are created by
mutations in the signature genes and pathways thought to be
driving forces in a homologous human cancer. This was not
necessarily an expected result since fly and human glia show many
biological differences despite displaying important similarities
[9,55,56]. Through genetic analysis of our model, we identified
crucial downstream effectors of EGFR and PI3K signaling, many
of which are mutated and/or activated in human glioma. These
effectors act in a combinatorial network to coordinately stimulate
cell cycle entry and progression, block cell cycle exit, and promote
inappropriate cellular growth and migration (Figure 8J). Pathways
within this network, while interdependent, act synergistically,
rather than additively. Thus, Drosophila shows evolutionary
conservation of oncogene cooperation.
At least four pathway circuits are necessary for glial neoplasia
initiated by EGFR and PI3K signaling, including dRas and dMyc
circuits, which induce dCyclinE and dCyclinD to drive cell cycle
entry, a Pnt circuit, which induces Stg to promote cell cycle
progression, and a Tor-eIF4E-S6K pathway, which provides
protein translation necessary for proliferation and growth
(Figure 8J). When activated individually, these pathways fail to
elicit glial neoplasia, implying a requirement for coordinated
stimulation of multiple effectors and inactivation of negative
regulators. Orthologs for many of the genes within these pathways,
such as dRictor, are implicated in human glioma, although specific
roles for some, such as ETS transcription factors, have not been
defined despite their expression in glioma [2,57,58]. While many
of these genes are known EGFR and PI3K pathway components,
we did not necessarily expect them to be required for EGFR and
PI3K dependent glial neoplasia. Indeed, we have tested many
other pathway components and outputs, such as Jun kinase, that
did not significantly suppress repo.dEGFR
l;dp110
CAAX phenotypes
upon reduced function (unpublished data).
Coactivation of EGFR and PI3K signaling upregulates dMyc,
which is necessary for glial neoplasia. This is consistent with
findings that, in flies and mammals, EGFR-Ras, PI3K, and Tor
signaling upregulate Myc protein levels [16,49,51,59,60]. Myc
oncogenes are well-known to cooperate with RTK-Ras signaling
to drive neoplastic transformation [51], and we demonstrate that
this property of Myc is conserved in flies. We also observed
sensitivity to reduced Myc gene dosage in our glioma model,
which has also been recently documented in a mouse model of
PTEN-dependent glioma [61]. c-myc is commonly amplified in
gliomas [62], implying that Myc is rate limiting, and c-myc
amplification may be selected for this reason. D-cyclins, estab-
lished Myc target genes, and Cdk4 are also commonly amplified
and/or overexpressed in gliomas [1,51]. We observed dMyc-
dependent dCyclinD overexpression, and a requirement for
dCyclinD-dCdk4 in repo.dEGFR
l;dp110
CAAX neoplasia, although
dCdk4 itself is not required for normal glial proliferation. Together
with our analysis of TORC2, this illustrates that oncogenic EGFR-
PI3K co-opts effectors that do not control normal glial
development. Similarly, cdk4
2/2 mutant mice show normal
proliferation in many tissues, but are resistant to ErbB-2-driven
breast cancers [63,64]. Our data argue that Cdk4 activity is a key
tumor-specific rate-limiting output of EGFR and PI3K signaling in
glioma as well.
In contrast to glia, coactivation of EGFR-Ras and PI3K in
neuroblasts, which are fly neural stem cells, does not promote
unchecked proliferation, despite the fact that neuroblasts express
dMyc and are capable of undergoing neoplastic transformation in
response to other genetic mutations [21]. Thus, in Drosophila,
neither a neural stem cell fate nor Myc activity confer competence
to undergo EGFR-PI3K neoplastic transformation. Rather, our
results suggest that neoplastic cells arise from committed glial
progenitors: dEGFR-dRas85D;dPTEN
2/2 clones derived from
progenitor cells produce large tumors, and anaplastic cells in
repo.dEGFR
l;dp110
CAAX brains are concentrated in regions
enriched for glial progenitors. Notably, regulated developmental
signaling through the EGFR pathway promotes proliferation of
normal Repo-expressing glial progenitors [27], and our results
show that constitutive EGFR and PI3K signaling prolongs this
proliferative progenitor state. Further studies of Drosophila glial
progenitors and glioma-like cells may illuminate the cellular
origins of human gliomas, which are thought to arise from
progenitor-like glial cells. Moreover, our results argue that cell-
type specific factors govern glial neoplasia. One such factor may be
Dap, the single p21/p27 ortholog, which is normally expressed in
only 5% of all glia (Figure S4). Perhaps glial progenitors do not
express Dap, whereas neuronal progenitors do [26], and this
underlies susceptibility to transformation by EGFR-Ras and PI3K.
Dap is highly regulated in a cell-type specific manner [26], and
studies of Dap regulation in glia may further illuminate the genetic
Figure 8. Myc overexpression or Rb loss synergizes with EGFR. (A–G) 2 mm optical sections of larval brain hemispheres from late 3
rd instar
larvae, displayed at the same scale. 20 mm scale bars. Frontal sections, midway through brains. Anterior up; midline to left. Glial cell nuclei are labeled
with Repo (red); glial cell bodies and membranes are labeled with CD8GFP (green) driven by repo-Gal4; HRP (blue) reveals neuropil at high intensity
and neuronal cell bodies at low intensity. repo.dMyc brains (C) contain many glia with enlarged nuclei (arrows). repo.dEGFR
l;dMyc (D) brains have
excess glia (red) throughout the brain, and these glia have very compact cell bodies (green) relative to wild-type glia (B). repo.dEGFR
l;dCyclinD;dCdk4
(E) and repo.dEGFR
l;Rbf1
dsRNA (F) brains display increased numbers of glia (red) relative to wild-type (B), but show a less severe glial phenotype and a
more normal neuronal compartment (blue) than either repo.dEGFR
l;dp110
CAAX (A) or repo.dEGFR
l;dMyc (D). The combination of
repo.Rbf1
dsRNA;dEGFR
l;dp110
CAAX (G) enhances neoplasia, leading to a dramatic increase in aberrant glia. (H,I) dCyclinE expression (red) in
repo.dEGFR
l;dp110
CAAX glia (H) and in repo.dEGFR
l;dp110
CAAX;Rbf1
dsRNA glia (I), alone and overlaid with the Repo glial marker (blue, right panels).
dCyclinE is more strongly and more broadly expressed in neoplastic glia upon Rbf1 loss, as evidenced by the increased number and intensity of
dCyclinE-expressing glial nuclei in (I) compared to (H). Anterior is up, midline to the left. 4.5 mm optical projections; 20 mm scale bars. (J) Pathway
diagram of key effectors involved in glial neoplasia initiated by EGFR and PI3K, showing the pathway circuits driving cell cycle entry and progression,
and protein translation. Arrows indicate pathway connections, although these connections are not necessarily direct. Genotypes: (A) UAS-dEGFR
l UAS-
dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (B) repo-Gal4 UAS-CD8GFP/+, (C) UAS-dMyc/repo-Gal4 UAS-CD8GFP, (D) UAS-dEGFR
l/+; repo-Gal4 UAS-CD8GFP/
UAS-dMyc, (E) UAS-dEGFR
l/+; UAS-dCyclinD UAS-dCdk4/+; repo-Gal4 UAS-CD8GFP, (F) UAS-dEGFR
l/+; repo-Gal4 UAS-CD8GFP/UAS-Rbf1
dsRNA, (G) UAS-
dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-Rbf1
dsRNA, (H) UAS-dEGFR
l UAS-dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/+, (I) UAS-dEGFR
l UAS-
dp110
CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-Rbf1
dsRNA.
doi:10.1371/journal.pgen.1000374.g008
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underlie the tumorigenic response of mammalian glial progenitors
to constitutively active EGFR [65].
While EGFR-Ras and PI3K are commonly upregulated in
gliomas and experimental models demonstrate that these pathways
are required for tumorigenesis, therapies that target EGFR and
PI3K signaling have proven disappointing. This discrepancy
between clinical and experimental data has many possible
explanations. For example, recent studies have demonstrated that
EGFR inhibitors are attenuated by particular mutations found in
glioma cells, such as PTEN loss or RTK co-amplification [2].
Addressing these and other possibilities remains a challenge that
dictates a need for new experimental models. The results
presented here establish Drosophila as a viable model system for
the study of glioma, offering a complex organismal system for
rapidly identifying and evaluating therapeutic targets using genetic
approaches. Such a system may be especially useful for
distinguishing those genetic mutations and pathways that drive
tumorigenesis from the large number of genes that show mutations
and altered expression in glioblastomas uncovered by recent
genomic analyses of patient samples [66,67]. Our studies have
already identified key rate-limiting genes, such as dCyclinE, Stg,
and dMyc, and genes only required for abnormal neoplastic glial
proliferation, such as dSin1, dRictor, and dCdk4, which may
represent important therapeutic targets in human gliomas.
Materials and Methods
Fly Stocks, Genetics, and Culture Conditions
Flies were cultured at 25uC. All genotypes were established by
standard genetics. To assess larval brain overgrowth phenotypes,
embryos were collected for 6–24 hrs, grown for 120–140 hrs, and
wandering 3
rd instar larvae were selected for dissection.
Stocks were obtained from the Bloomington Stock Center
unless otherwise noted. Other than UAS-PTEN
dsRNA lines from
Bloomington, all UAS-dsRNA lines were obtained from the VDRC
stock center [11]. The following stocks were obtained from other
investigators: UAS-dEGFR
l (T. Schubach), UAS-dEGFR
Elp, UAS-
dEGFR
wild-type (N. Baker), UAS-dPTEN, FRT
40A dPTEN
2L117, UAS-
dFoxO
SA (S. Oldham), UAS-dap (I. Hariharan), UAS-dp110
wild-type,
UAS-dCycD, UAS-dCdk4, UAS-dMyc, dMyc
4 (B. Edgar), UAS-Rbf1
(N. Dyson), appl-Gal4 (K. Finley), pros-Gal4 (B. Ohlstein), wor-Gal4
(C. Doe), gcm-Gal4 (V. Hartenstein), dTor
2L7, dTor
l(2)k17004 (R.
Bodmer), dRictor
D2 (S. Cohen), and stg
CB03726 (A. Spradling)
UAS-dsRNA Validation
UAS-dMyc
dsRNA, UAS-TSC1
dsRNA lines were validated in prior
publications [48]. UAS-dsRNA lines were crossed to actin-Gal4, ey-
Gal4, and GMR-Gal4 to assess phenotypes. Lines that showed
phenotypes inconsistent with known phenotypes for their target
genes were excluded from analysis. Gene knock-down in repo-Gal4
glia was verified with immunohistochemical stains for the
following constructs: UAS-dMyc
dsRNA, UAS-dAkt
dsRNA, UAS-
dS6K
dsRNA, UAS-eIF4E
dsRNA, UAS-Rbf1
dsRNA, and UAS-pnt
dsRNA
(Figure S11).
Abdominal Transplants
Larval brains were dissected into sterile PBS, washed, and cut
into fragments. Abdominal incisions were made in virgin female
hosts and single brain fragments were inserted. Hosts were
cultured for 1–6 weeks, dissected and fixed in 4% paraformalde-
hyde, incubated in 10% sucrose and embedded in O.C.T. Thick
50 mm sections were stained as described below.
Clonal Analysis
For hs-FLP clones, genotypes are indicated in figure legends.
Flies were initially grown at 18uCo r2 0 uC to minimize
spontaneous clones, which occurred at a low frequency during
late larval-pupal stages. 3
rd instar larvae, 0–48 hr pupae, or 0–2
day old young adults were treated with heat shock to induce clones
and subsequently cultured at 25uC for 1–4 weeks. For ey-FLP
clones, flies were cultured at 25uC continuously.
Immunohistochemistry and Imaging
Larval tissue was fixed for 30–50 minutes in 16PBS 4%
paraformaldehyde. Adult brains were fixed for 1–2 hr in 16PBS
4% paraformaldehyde or in PLP with 2% paraformaldehyde. For
BrdU labeling, larvae were cultured in food with 1 mg/ml BrdU
for 4–6 hrs, and fixed larval brains were treated with 2 N HCl for
30 minutes followed by DNase for 1 hr. Stains were performed in
16PBS 10% BSA with 0.3% Triton-X100 for larval brains and
0.5% Triton-X100 for adult samples.
The following antibodies were obtained from the Developmen-
tal Studies Hybridoma Bank and diluted 1:5–1:10: 8D12 anti-
Repo, anti-dMMP1, anti-dCyclinB, anti-Elav, and 40-1a anti-
lacZ. Larval and/or adult brains were also stained with rabbit
anti-Repo (G. Technau, 1:500), rat anti-dCyclinE (H. Richardson,
1:100), anti-BrdU (BD, 1:100), rat anti-Miranda (C. Doe, 1:100),
mouse anti-diphospho-Erk (Sigma, 1:200), mouse anti-Rbf1 (N.
Dyson, 1:5), mouse anti-Dap (I. Hariharan, 1:10), rabbit anti-
PntP1 (J. Skeath, 1:500), rabbit anti-eIF4E (P. Lasko, 1:100),
rabbit anti-dMyc (D. Stein, 1:1000), and anti-phospho-MPM2
(Upstate Biotechnology, 1:200). Anti-HRP-Cy5 and anti-HRP-
Cy3 (Jackson Labs) were used at 1:250–1:500. Secondary
antibodies were conjugated to Cy3 (Jackson Labs) or Alexa-488
or Alexa-647 (Molecular Probes). Actin was visualized with
Rhodamine-labeled phalloidin (Invitrogen).
Brains were imaged as whole mounts on a Zeiss LSM 510
confocal system. Images were analyzed in Zeiss LSM Image
Browser and processed in Photoshop CS3. For experiments in
which protein levels were compared between genotypes, all sample
preparation, histochemistry, imaging, and image processing was
performed in parallel in the same manner.
Supporting Information
Figure S1 Diagram of Drosophila EGFR mutant forms. Proteins
are shown as horizontal bars along which functional domains are
indicated, and the locations of alterations in mutant forms are
noted. Wild-type human EGFR and Drosophila EGFR (dEGFR)
show extensive conservation, with 55% homology in the kinase
domain and 41% homology in the ligand-binding portion of the
extracellular domain, which includes extensive cysteine repeats.
The signal peptide is labeled in yellow. Following the signal
peptide, the entire cytoplasmic domain is replaced with the
lambda dimerization domain in dEGFR
l, which causes constitu-
tive activation. Both human EGFR and dEGFR show extensive
cysteine repeats in the extracellular domain, indicated in blue. The
tyrosine kinase domain is labeled in magenta. The Elp mutant
form of dEGFR contains an A887T substitution in the N-lobe of
the kinase domain, which causes constitutive activation.
Found at: doi:10.1371/journal.pgen.1000374.s001 (0.23 MB TIF)
Figure S2 Coactivation of Ras-Raf and PI3K in Drosophila glia
causes neoplasia. 2 mm optical sections of representative larval
brain hemispheres from wandering 3rd instar larvae (A–H) and an
early 2nd instar larval brain (I), all displayed at the same scale.
20 mm scale bars. Frontal sections; midway through brains.
Anterior up; midline to left. Glial cell nuclei are labeled with
A Drosophila Model for Glioma
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glial cell bodies and membranes. An anti-HRP counterstain (blue)
reveals neuropil (neuronal fiber tracts) at high intensity and some
cell bodies of neurons and neuronal precursors at low intensity,
and this varies slightly according to exact plane of section and
mutant phenotype. repo.dEGFRl;dp110CAAX (A), repo.
dRas85DV12;dPTENdsRNA (B), and repo.dRafgof;dp110CAAX (C)
brains show increased numbers of glia relative to wild-type (D),
repo.dRas85DV12 alone (E), or repo.dPTENdsRNA alone (F).
Compared to wild-type (D), repo.dEGFRwild-type (H) brains show
reduced neurons (HRP, low intensity blue), which renders glia
more densely packed and the entire brain smaller than normal.
However, repo.dEGFRwild-type brains (H) do not show a
substantial increase the number of glia compared to wild-type
(D). Brains of repo.dEGFRElp 2nd instar larvae (I) show substantial
neuron loss, brain malformation, and excess glia for that stage of
development. Genotypes: (A) UAS-dEGFRl UAS-dp110CAAX/+;
repo-Gal4 UAS-CD8GFP/+ (B) UAS-CD8GFP/+; repo-Gal4/UAS-
dRas85DV12 UAS-dPTENdsRNA (C) UAS-dp110CAAX; repo-Gal4
UAS-CD8GFP/UAS-dRafgof (D) repo-Gal4 UAS-CD8GFP/+ (E) repo-
Gal4 UAS-CD8GFP/UAS-dRas85DV12 (F) UAS-CD8GFP/+; repo-
Gal4/UAS-dPTENdsRNA (G) UAS-dEGFRl/+; repo-Gal4 UAS-
CD8GFP/+ (H) UAS-CD8GFP/+; repo-Gal4/UAS-dEGFRwild-type
(I) UAS-CD8GFP/+; repo-Gal4/UAS-dEGFRElp.
Found at: doi:10.1371/journal.pgen.1000374.s002 (10.31 MB
TIF)
Figure S3 dMMP1 expression in wild-type and dEGFR
l;dp110-
CAAX glia. (A,B) 3rd instar larval brains. Frontal sections, showing
medial regions enriched for proliferating glia. Anterior up; midline
to left. 4.5 mm optical projections, matched in scale. 20 mm scale
bars. Expression of the active form of dMMP1 (red) in wild-type
(A) and repo.dEGFRl;dp110CAAX brains (B), shown alone (left
panels) and overlaid with an HRP (blue) neuronal label and a
CD8GFP (green) glial label (right panels). In wild-type brains, glia
(‘G’) rarely express active dMMP1, although some glia on the
surface of the brain show low levels of dMMP1 staining (arrow). In
repo.dEGFRl;dp110CAAX brains (B), some neoplastic glia (‘G’)
express active dMMP1 (red in right panel, yellow in overlay),
which is largely membrane-localized in individual cells (arrow).
Genotypes: (A) UAS-CD8GFP/+; repo-Gal4/+ (B) UAS-dEGFRl
UAS-dp110CAAX/+; UAS-CD8GFP/+; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s003 (3.93 MB TIF)
Figure S4 Glial-specific Rbf1 knock-down or overexpression of
G1 Cyclin-Cdks, Dap, and Rbf1 affects glial proliferation. (A–F)
2 mm optical sections of larval brain hemispheres from wandering
3rd instar larvae displayed at the same scale. 20 mm scale bars.
Frontal sections; midway through brains. Anterior up; midline to
left. Glial cell nuclei are labeled with Repo (red). Glial cell bodies
and membranes are labeled with CD8GFP (green) driven by repo-
Gal4. HRP counter-staining (blue) reveals neuropil at high
intensity and some cell bodies of neurons and neuronal precursors
at low intensity. Rbf1 knock-down in repo.Rbf1dsRNA (B) does not
significantly alter glial cell numbers (red nuclei) compared to wild-
type (A). Ectopic expression of dCyclinE-dCdk2 (C) or dCyclinD-
dCdk4 in repo-Gal4-glia promotes an approximate doubling of glial
cells numbers (red nuclei), even when combined with Rbf1
dsRNA
(D). Continuous expression of Dap (E) or Rbf1 (F) in otherwise
wild-type repo-Gal4-glia substantially reduces glial cell numbers,
showing that repo-Gal4 glia normally undergo proliferation
controlled by dCyclinE-dCdk2 and Rbf1-E2F1. Genotypes: (A)
UAS-CD8GFP/+; repo-Gal4/+ (B) UAS-CD8GFP/+; repo-Gal4/UAS-
Rbf1dsRNA (C) UAS-CD8GFP/+; repo-Gal4/UAS-dCyclinE UAS-
dCdk2 (D) UAS-CD8GFP/UAS-dCyclinD UAS-dCdk4; repo-Gal4/
UAS-Rbf1dsRNA (E) UAS-dap/+; UAS-CD8GFP/+; repo-Gal4/+ (F)
UAS-CD8GFP/+; repo-Gal4/UAS-Rbf1.
Found at: doi:10.1371/journal.pgen.1000374.s004 (8.27 MB TIF)
Figure S5 Dap and Rbf1 expression in wild-type and
dEGFR
l;dp110
CAAX glia. 3rd instar larval brains. Frontal
sections, showing superficial dorsal regions enriched for Dap-
and Rbf1-expressing cells. Anterior up; midline to left. 7 mm
optical projections, all matched in scale. 20 mm scale bars. (A,B)
Dap expression (red) in wild-type (A) and repo.dEGFRl;dp110-
CAAX brains (B), shown alone (left panels) and overlaid with Repo
(blue) and repo.CD8GFP (green) glial markers (right panels). In
both genotypes, Dap is primarily expressed in neuroblasts (‘NB’)
and ganglion mother cell neuronal precursors (‘NP’), rarely in glia
(‘G’), and almost never in neurons (‘N’). In repo.dEGFRl;dp110-
CAAX brains, Dap is rarely expressed in glia as seen by the lack of
substantial overlap between Dap expression and glial markers (B,
right panel). White arrows denote rare Dap-positive glia in both
wild-type and repo.dEGFRl;dp110CAAX brains; these glia show
lower levels of Dap protein than neighboring neuroblasts and
neuronal precursors. Dap-positive glia were counted in 3
repo.dEGFRl;dp110CAAX brains and an average of 5% of all glia
expressed Dap (87 glia expressed Dap out of 1738 total glia
counted). (C–D) Rbf1 expression (red) in wild-type (E) and
repo.dEGFRl;dp110CAAX brains (F), shown alone (left) and
overlaid (right) with the CD8GFP (green) glial marker and HRP
(blue) neuronal marker. In both genotypes, Rbf1 is highly
expressed in glia (‘G’) and neuroblasts (‘NB’), which were
identified by their characteristic positions and large cell bodies.
Neurons (‘N’) show lower expression. Genotypes: (A,C) UAS-
CD8GFP/+; repo-Gal4/+ (B,D) UAS-dEGFRl UAS-dp110CAAX/+;
UAS-CD8GFP/+; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s005 (7.96 MB TIF)
Figure S6 dEGFR
l; dp110
CAAX glia do not express neuronal
and neuroblast markers. Late 3rd instar larval brains. Medial
anterior regions shown. Anterior up; midline to left. 2 mm optical
sections. CD8GFP (green), driven by the repo-Gal4 driver, labels
glial cell bodies and membranes. An HRP counter-stain (blue)
reveals neuropil at high intensity and cell bodies of neurons and
some neuronal precursors at low intensity. (A,B) Repo expression
(red) in glial cell nuclei in wild-type (A) and repo.dEGFRl;dp110-
CAAX brains (B). In wild-type brains, neuronal fibers and neurons
(blue) are enveloped by glial processes (green) to give the brain a
honeycombed appearance. In repo.dEGFRl;dp110CAAX brains,
neurons (‘N’) lack GFP or Repo expression, in contrast to glia
(‘G’). (C–D) Elav expression (red) in wild-type (C) and repo.
dEGFRl;dp110CAAX brains (D), shown alone (left panels) and
overlaid (right panels) with the CD8GFP (green) glial marker and
HRP (blue) neuronal marker. In both genotypes, Elav is highly
expressed in neurons (‘N’) but absent from glia (green cell bodies
indicated by white arrows). (E–F) Miranda expression (red) in wild-
type (E) and repo.dEGFRl;dp110CAAX (F) brains, shown alone
(left panels) and overlaid (right panels) with CD8GFP (green) glial
marker and HRP (blue) neuronal marker. In both genotypes,
Miranda is highly expressed in neuroblasts (‘NB’), which are
identified by their characteristic positions and large cell bodies, but
is absent from glia (green cell bodies, indicated by white arrows).
Genotypes: (A,C,E) UAS-CD8GFP/+; repo-Gal4/+ (B,D,F) UAS-
dEGFRl UAS-dp110CAAX/+; UAS-CD8GFP/+; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s006 (9.24 MB TIF)
Figure S7 dEGFR
l and dp110
CAAX do not induce neoplasia
from neurons, neuroblasts, or certain glia. Late 3rd instar larval
brain hemispheres. Medial anterior regions shown. Anterior up;
midline to left. 3.5 mm optical projections. Repo expression (red)
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reveals neuropil at high intensity and cell bodies of neurons and
some neuronal precursors at low intensity, and this varies slightly
according to variance in exact section plane. (A–D) Wild-type (A),
dEGFR
l; dp110
CAAX overexpressed using the 1407-Gal4 neuro-
blast driver (B), dEGFR
l; dp110
CAAX overexpressed using the
pros-Gal4 neural driver (C), and dEGFR
l;dp110
CAAX overex-
pressed using the gcm-Gal4 embryonic glial driver (D). In all cases,
dEGFR
l;dp110
CAAX overexpression did not induce neoplastic
overgrowth of glial or neuronal cell types, as determined by brain
size and cell-type specific stains. (E,F) Cytoplasmic GFP (green),
driven by the Nrv2-Gal4 driver, labels cell bodies and cytoplasmic
processes, as seen in wild-type (E). dEGFR
l;dp110
CAAX overex-
pressed using the Nrv2-Gal4 glial driver (B). Nrv2-Gal4 is expressed
by post-mitotic cortex glia, which proliferate somewhat in response
to dEGFR
l;dp110
CAAX to cause slight brain enlargement, but do
not become neoplastic like repo.dEGFRl;dp110CAAX glia. Geno-
types: (A) +/CyO (B) UAS-dEGFRl UAS-dp110CAAX/+; 1407-
Gal4/UAS-Gal4 (C) UAS-dEGFRl UAS-dp110CAAX/+; UAS-Gal4/
+; pros-Gal4/+ (D) UAS-dEGFRl UAS-dp110CAAX/+; gcm-Gal4/+
(E) Nrv2-Gal4 UAS-GFP/+; Nrv2-Gal4 UAS-GFP/+ (F) UAS-
dEGFRl UAS-dp110CAAX/+; Nrv2-Gal4 UAS-GFP/UAS-Gal4;
Nrv2-Gal4 UAS-GFP/+.
Found at: doi:10.1371/journal.pgen.1000374.s007 (7.96 MB TIF)
Figure S8 Coactivation of EGFR and PI3K in glial progenitors
creates invasive neoplastic glia.(A–E) FLP/FRT clones in adult
brains derived from a population of ey-FLP and repo-Gal4-
expressing cells. CD8GFP (green) marks cell bodies and
membranes of glial clones derived by FLP/FRT mitotic
recombination (see text). Repo (red) marks all glial cell nuclei, in
both clones and surrounding normal tissue. 8.5 mm confocal
optical sections through brains of similarly aged adults, all
matched to scale. 20 mm scale bars. Each panel shows half brains,
including a whole optic lobe and adjacent central brain. dEGFRElp
(C) and dPTEN2/2 (J) clones are composed of 2–5-fold more cells
than wild-type controls (H). In contrast, dEGFRl;dPTEN2/2 (D)
and dEGFRElp;PTEN2/2 double mutant clones form large
tumors visible in adult brains. As with hs-FLP clones, dEGFRl;dP-
TEN2/2 and dEGFRElp;dPTEN2/2 clones are less cellular and
more invasive than dRas85DV12;PTEN2/2 clones (see Figure 4).
Genotypes: (A) ey-flp/+; FRT40A tubGal80/FRT,40A; repo-Gal4
UAS-CD8GFP/+ (B) ey-flp/+; FRT40A tubGal80/FRT40A
PTEN2L117; repo-Gal4 UAS-CD8GFP/+ (C) ey-flp/+; FRTG13
tubGal80/FRTG13 UAS-CD8GFP; repo-Gal4/UAS-dEGFRElp (D)
ey-flp/UAS- dEGFRl; FRT40A tubGal80/FRT40A PTEN2L117;
repo-Gal4 UAS-CD8GFP/UAS- dEGFRl (E) ey-flp/+; FRT40A
tubGal80/FRT40A PTEN2L117; repo-Gal4 UAS-CD8GFP/UAS-
dEGFRElp.
Found at: doi:10.1371/journal.pgen.1000374.s008 (7.84 MB TIF)
Figure S9 Stg overexpression exacerbates EGFR-PI3K glial
neoplasia. 2 mm optical sections of larval brain hemispheres from
late 3rd instar larvae, displayed at the same scale. 20 mm scale
bars. Frontal sections, midway through brains. Anterior up;
midline to left. Glial cell nuclei are labeled with Repo (red); glial
cell bodies and membranes are labeled with CD8GFP (green)
driven by repo-Gal4. An HRP counter-stain (blue) reveals neuropil
at high intensity and neuronal cell bodies at low intensity. HRP
stains varied between the two samples according to effects of
mutant glia and slight variance in section plane. Stg co-
overexpression with dEGFR
l;dp110
CAAX (B) enhances neoplasia
compared to dEGFR
l;dp110
CAAX (A), leading to a dramatic
increase in aberrant glia and yielding a phenotype similar to that
of repo.Rbf1dsRNA;dEGFRl;dp110CAAX (see Figure 8G). Geno-
types: (A) UAS-dEGFRl UAS-dp110CAAX/+; repo-Gal4 UAS-
CD8GFP/+ (B) UAS-dEGFRl UAS-dp110CAAX/+; UAS-stg/+;
repo-Gal4 UAS-CD8GFP/+.
Found at: doi:10.1371/journal.pgen.1000374.s009 (6.27 MB TIF)
Figure S10 Knock-down and/or overexpression of dTor and
dTor effectors. 2 mm optical sections of larval brain hemispheres
from wandering 3rd instar larvae, approximately 130hr AED, all
displayed at the same scale. 20 mm scale bars. Anterior up; midline
to the left. Frontal sections; midway through brains. Repo (red)
marks glial cell nuclei; CD8GFP (green), driven by repo-Gal4, labels
glial cell bodies and membranes. An HRP-counter stain (blue)
reveals neuropil (neuronal fiber tracts) at high intensity and some
cell bodies of neurons and neuronal precursors at low intensity,
and this varies slightly according to exact plane of section, brain
orientation, and mutant phenotype. repo.dAktdsRNA brains (B) are
smaller and have fewer glia than wild-type controls (A). All other
genotypes have relatively normal sized brains. By gross examina-
tion, repo.TorTED (C), repo.dRaptordsRNA (E), repo.deIF4EdsRNA
(F) and repo.dS6KdsRNA (G) display an estimated 10–20%
reduction in glial cell numbers. repo.dTSC1dsRNA (D), repo.Rheb
(H) and repo.deIF4E (I) brains contain normal numbers of glia.
Genotypes: (A) repo-Gal4 UAS-CD8GFP/+ (B) UAS-CD8GFP/+;
repo-Gal4/UAS-dAktdsRNA (C) UAS-TorTED/UAS-CD8GFP; repo-
Gal4/+ (D) UAS-CD8GFP/+; repo-Gal4/UAS-dTSC1dsRNA (E)
UAS-dRaptordsRNA/UAS-CD8GFP; repo-Gal4/+ (F) UAS-CD8GFP/
+; repo-Gal4/UAS-deIF4EdsRNA (G) UAS-dS6KdsRNA; UAS-
CD8GFP/+; repo-Gal4/+ (H) UAS-CD8GFP/+; repo-Gal4/UAS-Rheb
(I) UAS-CD8GFP//UAS-deIF4E; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s010 (8.83 MB TIF)
Figure S11 Validation of dsRNA constructs. 2 mm optical
sections of larval brain hemispheres from wandering 3rd instar
larvae. Frontal sections. Anterior up, midline to the left. Each
individual staining pattern is shown alone (left panels) and with
overlaid glial or neuronal markers (right panels). Repo (blue) in
(A–J) marks glial cell nuclei. Glial cell bodies and membranes are
labeled with CD8GFP (green) driven by repo-Gal4. In (K,L) an
HRP counter-stain (blue) reveals neurons. Red marks histochem-
ical stains for each indicated protein in repo.dEGFRl;dp110CAAX
(A,C,E,G,I,K) and repo.dEGFRl;dp110CAAX with each indicated
dsRNA construct (B,D,F,H,J,L). Each dsRNA construct was
expressed with repo-Gal4 to yield glial-specific knock-down, which
left protein expression in surrounding neuronal tissue intact. For
the nuclear protein PntP1, knock-down was verified by the lack of
glial-specific staining in the presence of the pntdsRNA (B), although
PntP1 is present within neighboring neurons (‘N’). For dAkt,
deIF4E, and dS6K, gene knock-down was confirmed using
antibodies for total protein. Glial-specific reduction in gene
expression by dAktdsRNA and deIF4EdsRNA is highlighted by white
outlines in (D) and (F). dAkt protein is higher in neuronal tissue
(‘N’) in both repo.dEGFRl;dp110CAAX (C) and repo.dAktdsRNA;-
dEGFRl;dp110CAAX (D). deIF4E is high in dEGFR
l;dp110
CAAX
glia (E) and low in neurons (E,F). repo.deIF4EdsRNA;-
dEGFRl;dp110CAAX brains (F) have reduced glial eIF4E. Reduced
glial dS6K protein, which is diffusely cytoplasmic, is observed in
repo.dS6KdsRNA;dEGFRl;dp110CAAX brains (H) compared to
repo.dEGFRl;dp110CAAX (G). Reduced glial dMyc expression in
repo.dMycdsRNA;dEGFRl;dp110CAAX brains (J) is noted by white
outlines, and the absence of purple nuclei in overlay (J, right
panel), relative to repo.dEGFRl;dp110CAAX (I, right panel). dMyc
is highly expressed in neuroblasts (‘NB’) in both samples (I, J),
which do not express the dMycdsRNA. Glial Rbf1 protein is absent
in repo.dRbf1dsRNA;dEGFRl;dp110CAAX brains (L) in contrast to
neighboring neurons (‘N’) in ,repo.dEGFRl;dp110CAAX brains
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dp110CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-pntdsRNA (D) UAS-
dEGFRl UAS-dp110CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-
dAktdsRNA (F) UAS-dEGFRl UAS-dp110CAAX/+; repo-Gal4 UAS-
CD8GFP/UAS-deIF4EdsRNA (H) UAS-dEGFRl UAS-dp110CAAX/
UAS-dS6KdsRNA; repo-Gal4 UAS-CD8GFP/+ (J) UAS-dEGFRl UAS-
dp110CAAX/+; UAS-dMycdsRNA/+; repo-Gal4 UAS-CD8GFP/+ (L)
UAS-dEGFRl UAS-dp110CAAX/+; repo-Gal4 UAS-CD8GFP/UAS-
Rbf1dsRNA.
Found at: doi:10.1371/journal.pgen.1000374.s011 (9.04 MB TIF)
Figure S12 Phospho-MPM2 reveals increased S-phase and M-
phase glia in repo.dRbf1dsRNA;dEGFRl;dp110CAAX brains. (A–C)
phospho-MPM2 expression (red) in wild-type brains (A), repo.
dEGFRl;dp110CAAX brains (B), and repo.dRbf1dsRNA;-
dEGFRl;dp110CAAX brains (C). 20 mm scale bars. Anterior up,
midline to the left. 6 mm optical projections showing representative
superficial dorsal regions enriched for mitotic glia. Phospho-
MPM2 shown alone (left panels), overlaid with the Repo (blue,
middle panels), and CD8GFP (green, right panels) glial markers.
Phospho-MPM2 nuclear foci are present in S-phase cells (arrows
note examples). S-phase glia are clearly visible in the middle panel
as purple cells with MPM2 foci, which appear enriched in
repo.dRbf1dsRNA;dEGFRl;dp110CAAX brains (C) relative to re-
po.dEGFRl;dp110CAAX brains (B). In all genotypes, high levels of
phospho-MPM2 is also expressed in mitotic cells (asterisks note
examples). Mitotic glia showed low levels of Repo (middle panels),
but are clearly GFP-positive (right panels), suggesting that Repo
protein expression is reduced upon mitosis in glia. repo.dRbf1dsR-
NA;dEGFRl;dp110CAAX brains (C) also show increased density of
phospho-MPM2-positive mitotic glia compared to repo.
dEGFRl;dp110CAAX brains (B). In wild-type (A), the majority of
phospho-MPM2-postive cells are not glial and are neuroblasts or
neuronal precursors, as revealed by the lack of overlap between
phospho-MPM2 staining (middle panel) and the Repo and
CD8GFP markers. Genotypes: (A) repo-Gal4 UAS-CD8GFP/+ (B)
UAS-dEGFRl UAS-dp110CAAX/+; UAS-CD8GFP/+; repo-Gal4/+
(C) UAS-dEGFRl UAS-dp110CAAX/+; repo-Gal4 UAS-CD8GFP/
UAS-Rbf1dsRNA.
Found at: doi:10.1371/journal.pgen.1000374.s012 (8.99 MB TIF)
Table S1 Overexpression of EGFR-Ras and PI3K-Akt path-
ways in Drosophila glia.
Found at: doi:10.1371/journal.pgen.1000374.s013 (0.08 MB PDF)
Table S2 Coactivation of EGFR and PI3K does not elicit
neoplasia in all neural cell types.
Found at: doi:10.1371/journal.pgen.1000374.s014 (0.08 MB PDF)
Table S3 Genetic analysis of Akt, Tor, Myc, and CyclinD-Cdk4
pathways in neoplastic and normal glia.
Found at: doi:10.1371/journal.pgen.1000374.s015 (0.10 MB PDF)
Video S1 An animated 7.5 mm thick confocal z-stack of
dEGFR
l; dp110
CAAX tumor cells derived from transplanted larval
glia, pictured in Figure 3D. The depth of each frame is noted in
the upper left-hand corner. 20 mm scale bar for x/y-axis.
Transplanted mutant glia are labeled with membrane bound
CD8GFP (green) and the Repo nuclear protein (blue). Actin
staining (red, phalloidin) reveals abdominal anatomy of the host.
Asterisks indicate trachea embedded in the pictured
dEGFR
l;dp110
CAAX tumor, visible as hollow actin-positive (red)
tubules running through tissues. Genotypes: Hosts were w1118
virgin females. Transplanted glia were UAS-dEGFRl UAS-
dp110CAAX/+; UAS-CD8GFP/+; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s016 (1.54 MB
MOV)
Video S2 An animated 27 mm thick confocal z-stack of
dEGFR
l; dp110
CAAX tumor cells derived from transplanted larval
glia, pictured in Figure 3F. The depth of each frame is noted in the
upper left-hand corner. 20 mm scale bar for x/y-axis. Transplant-
ed mutant glia are labeled with membrane bound CD8GFP
(green) and the Repo nuclear protein (blue). Actin staining (red,
phalloidin) reveals abdominal anatomy of the host. Arrowheads in
indicate dEGFR
l;dp110
CAAX glial cells invading an ovary,
distinguished by its characteristic actin staining (bright red). An
asterisk indicates trachea embedded in this dEGFR
l;dp110
CAAX
tumor, visible as a hollow actin-positive (red) tubule running
through the tissue. Genotypes: Hosts were w1118 virgin females.
Transplanted glia were UAS-dEGFRl UAS-dp110CAAX/+; UAS-
CD8GFP/+; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s017 (1.16 MB
MOV)
Video S3 An animated 88 mm thick confocal z-stack of a hs-
FLP/FRT clone of dPTEN2/2;dRas85DV12 cells pictured in
Figure 4E. The depth of each frame is noted in the upper left-hand
corner. 20 mm scale bar for x/y-axis. Approximately half of the
affected brain is displayed, with the midline to the left. The
dPTEN2/2;dRas85DV12 mutant cells are labeled with mem-
brane-bound CD8GFP (green) and penetrate through the entire
depth of the brain, some of which is visible as red background.
These dPTEN2/2;dRas85DV12 cells appear to originate in the
optic lobe (right) and extend variable tendrils into the central brain
(middle, left). Genotype: hs-flp1/+; FRT40A tubGal80/FRT40A
PTEN2L117; repo-Gal4 UAS-CD8GFP/UAS-dRas85DV12.
Found at: doi:10.1371/journal.pgen.1000374.s018 (1.06 MB
MOV)
Video S4 An animated 16 mm thick confocal z-stack of a hs-
FLP/FRT clone of wild-type cells pictured in Figure 4A. The
depth of each frame is noted in the upper left-hand corner. 20 mm
scale bar for x/y-axis. Midline to the left. This clone of normal glia
is labeled with membrane-bound CD8GFP (green) and shows cells
in a cell-body rich region of the central brain adjacent to the optic
lobe. The clone is composed of 2 cells with extensive cytoplasmic
projections. Genotype: hs-flp1/+;FRTG13 tubGal80/FRTG13 UAS-
CD8GFP; repo-Gal4/+.
Found at: doi:10.1371/journal.pgen.1000374.s019 (0.24 MB
MOV)
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